NVIDIA and Eli Lilly launch up to $1 billion AI co-innovation lab
NVIDIA and Eli Lilly announced a co-innovation AI lab in the San Francisco Bay Area, where Lilly scientists will work alongside NVIDIA AI engineers on drug discovery. The two companies will invest up to $1 billion over five years in talent, infrastructure and compute. The lab's infrastructure will be built on BioNeMo and the Vera Rubin architecture.
- Up to $1 billion over five years, split between talent, infrastructure and compute
- Lab based in the San Francisco Bay Area; work expected to begin in South San Francisco
- Built on NVIDIA BioNeMo and the Vera Rubin architecture
- Also uses Omniverse, RTX PRO Servers, Clara and Lilly TuneLab
NVDA around the story · hourly24 h reaction ▲ 1.21%
Source
NVIDIA Investor RelationsJan 12, 2026